Effects of an Independent Walking Program With Walking Poles in People With Parkinson Disease

NCT07551661 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-04-27

No results posted yet for this study

Summary

Study Purpose: The purpose of the study is to compare changes in walking in people with Parkinson disease after an 8-week independent walking program with or without using walking poles.

Major parts of the Study:

Before the walking program: Measurements will be taken of you while you are walking. You will be given tests and questionnaires about your movement and thinking. You will be trained on how to use walking poles.

Independent walking program: You will be asked to walk at least 3 times each week for 8 weeks and keep a log of your walking. If you are in the walking pole group, you will walk with the poles. After the walking program: Your walking, movement, and thinking measurements will be collected as before the walking program.

Follow-up: The same measures of walking, movement, and thinking will be taken 3-months after ending the walking program.

Conditions

  • PARKINSON DISEASE (Disorder)

Interventions

BEHAVIORAL

Independent walking program using walking poles

Participants will independently walk at least 3 times a week for 8 weeks using walking poles

BEHAVIORAL

Independent walking program without walking poles

Participants will independently walk at least 3 times a week for 8 weeks without walking poles

Sponsors & Collaborators

  • East Tennessee State University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-30
Primary Completion
2026-10-31
Completion
2027-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07551661 on ClinicalTrials.gov